ImmunityBio, Inc. Common Stock

IBRX us
$8.44
▼ 0.20 (-2.31%)
Volume: 5,765,147 · 2026-09-25

📈 Price Chart

Loading…
RSI (14)

🧭 Style Verdicts

🚀 Momentum 64
  • 21d momentum +2.3%
  • MA aligned bullish
  • RSI 53
🎯 Pullback 50
  • +2.4% vs 20MA
💎 Value 58
  • -32% off 52w high

Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.

📐 Technicals

RSI(14)53.2
MACD+0.032
MA trendBullish
ATR6.09%
21d mom.+2.3%
63d mom.-3.1%
vs 20MA+2.4%
RVOL(20)0.55×
52w low · 2 52w high · 12
-32.1% from 52-week high
20d support 8 · resistance 9

Computed live from daily OHLCV · as of 2026-09-25

🏦 Fundamentals

Market cap$9.2B
PER—
PBR-8.75
PSR55.23
EPS$-0.94
ROE94.8%
ROA-157.9%
Dividend yield0.00%
Debt/Equity-0.40
EV/EBITDA-40.38
week1M3M6M1YYTD
-0.47% +2.30% -3.10% +14.36% +237.60% +317.82%

Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.

⚖️ AI Bull vs Bear

🐂 Bull
6/10
🐻 Bear
6/10

14d momentum +4.46%, daily vol 3.99%. ImmunityBio, Inc. Common Stock sits in a mixed regime.

Derived from 14-day momentum and daily volatility on real OHLCV.

🗞 Related News

No recent news.